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Cytokine receptor signals have been suggested to stimulate cell differentiation during 
hemato/lymphopoiesis. Such action, however, has not been clearly demonstrated. Here, we 
show that adult B cell development in 
 
IL-7
 
 
 
/
 
 
 
 and 
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice is arrested at the pre–pro-B 
cell stage due to insufficient expression of the B cell–specific transcription factor EBF and 
its target genes, which form a transcription factor network in determining B lineage 
specification. EBF expression is restored in 
 
IL-7
 
 
 
/
 
 
 
 pre–pro-B cells upon IL-7 stimulation or 
in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 pre–pro-B cells by activation of STAT5, a major signaling molecule downstream 
of the IL-7R signaling pathway. Furthermore, enforced EBF expression partially rescues B 
cell development in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice. Thus, IL-7 receptor signaling is a participant in the 
formation of the transcription factor network during B lymphopoiesis by up-regulating EBF, 
allowing stage transition from the pre–pro-B to further maturational stages.
 
B cell development is regulated by multiple B
cell–specific transcription factors (1, 2). Both
E2A and EBF are necessary for initiating B cell
differentiation through the cooperative regula-
tion of B cell–specific genes, such as 
 
RAG1
 
,
 
RAG2
 
, 
 
Ig
 
 
 
, 
 
Ig
 
 
 
, 
 
 
 
5
 
, 
 
Vpre-B
 
, and 
 
CD19
 
 (1, 2).
Another transcription factor, PU.1, as well as
E2A can up-regulate the promoter activity of
the 
 
EBF
 
 gene (3, 4). Moreover, 
 
Pax5
 
 gene ex-
pression is regulated by E2A and EBF (5).
Once Pax5 is expressed, B cell progenitors are
irreversibly committed to B cell lineage (6).
Therefore, hierarchical regulation of these tran-
scription factors may be a key for acquisition of
B lineage specificity in B cell progenitors. It
remains unclear, however, whether the forma-
tion of this transcription factor network occurs
in a cell autonomous manner or requires extra-
cellular stimuli provided by stromal cells in
bone marrow.
Flt3 ligand, stem cell factor (SCF), and IL-7
are important cytokines for B cell development
(7–9). Among these cytokines, only IL-7 can
promote stage transition from B220
 
 
 
CD19
 
 
 
pre–pro-B cells to B220
 
 
 
CD19
 
 
 
 pro-B cells,
whereas Flt3 ligand or SCF enhances the pro-
liferation of B cell progenitors in in vitro cul-
tures (10). Studies from 
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice re-
ported conflicting results of the stage at which
B cell development is arrested. One paper sug-
gests a role of IL-7R signaling in regulation of
 
IgH
 
 gene rearrangement for transition from
pro-B to pre-B stage (11). Other papers indi-
cate that B cell development in 
 
IL-7R
 
 
 
 
 
/
 
 
 
mice is arrested at an earlier point than the
pro-B/pre-B transition stage, such as the early
pro-B stage (using Hardy’s nomenclature, frac-
tion B; references 12, 13) or even earlier at the
common lymphoid progenitor (CLP) stage
(14). Furthermore, impaired T cell develop-
ment in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 or 
 
 
 
c
 
 
 
/
 
 
 
 mice is rescued
by enforced Bcl-2 expression, but rescue of B
cell development is not observed in the same
mice (15–17), suggesting that the primary
function of IL-7R signaling is not to maintain
cell survival but to promote cell differentiation
and/or stimulate cell proliferation during B
cell development. Together, these observa-
tions imply a role of IL-7 in stage transition
during early adult B cell development. None-
theless, the molecular basis of its function re-
mains totally unknown.
In this study, we clarified that B cell devel-
opment is arrested at the pre–pro-B cell stage
in the absence of IL-7R signaling. We investi-
gated the role of IL-7R in expression of B
cell–specific factors at this developmental stage.
We found a direct connection between IL-7R
signaling and up-regulation of EBF expres-
sion. This finding demonstrates an indispens-
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able role of IL-7 in the formation of transcription factor net-
works during adult B cell development.
 
RESULTS AND DISCUSSION
B cell development is arrested at the pre–pro-B cell stage in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 and 
 
IL-7
 
 
 
/
 
 
 
 mice
 
To clarify the role of IL-7R signaling in B cell development,
we first confirmed the stage at which B cell development is
blocked in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 and 
 
IL-7
 
 
 
/
 
 
 
 mice (see Fig. 1 A for
defined stages of B cell development). Consistent with a pre-
vious paper (14), we found that there was no difference in
the number of CLPs between 
 
IL-7
 
 
 
/
 
 
 
 and WT mice (Fig. 1
D). Next, we analyzed the more mature B220
 
 
 
CD43
 
 
 
 pop-
ulation, which is downstream of CLPs and include the pre–
pro-B and pro-B fractions (Fig. 1 A). Total number of
B220
 
 
 
CD43
 
 
 
BP-1
 
 
 
HSA
 
 
 
/low
 
 subset (fraction A in Hardy’s
nomenclature [13]) in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 and 
 
IL-7
 
 
 
/
 
 
 
 mice were
also comparable to WT mice (unpublished data). Fraction A
contains non-B cell progenitors that express NK1.1 or Ly-
6C (18, 19). Therefore, we also compared the number of
NK1.1
 
 
 
Ly-6C
 
 
 
 cells in fraction A (pre–pro-B cells; Fig. 1
C) and found that the number of these cells were still com-
parable among WT, 
 
IL-7R
 
 
 
 
 
/
 
 
 
, and 
 
IL-7
 
 
 
/
 
 
 
 mice (Fig. 1
D). In contrast, B220
 
 
 
CD43
 
 
 
BP-1
 
 
 
HSA
 
high
 
 subset (fraction
B in Hardy’s nomenclature [13]) in 
 
IL-7R
 
 
 
 
 
/
 
 
 
 and 
 
IL-7
 
 
 
/
 
 
 
mice was rarely detected (Fig. 1, B and D). Cells in the next
Figure 1. B cell development is arrested at the pre–pro-B stage in 
the absence of IL-7R signaling. (A) Schematic maturational relationship 
of B cell populations used in this study. We excluded Ly-6C  and NK1.1  
cells from Hardy’s fraction A (reference 25) except for the experiments 
shown in Fig. 4. CD19 can be used instead of HSA to distinguish pre–pro-B 
(fraction A) and pro-B (fractions B and C/C ) cells (reference 13; Fig. S1 D, 
available at http://www.jem.org/cgi/content/full/jem.20050158/DC1). 
Hereafter, we used the fraction C/C  population as fraction C. (B) Bone 
marrow (BM) cells from 8-wk-old mice were stained with antibodies for 
lineage markers (Lin: CD3 , Gr-1, Ter119, and Mac-1), B220, CD43, BP-1, 
and HSA. Propidium iodide  dead cells as well as Lin  cells were excluded 
from this cell surface phenotyping. The numbers in FACS plots are per-
centages of cells in each cell population for each plot. The representative 
results of at least three independent experiments are shown. (C) The ex-
pression of IL-7R , c-Kit, Flt3, AA4.1, and HSA in pre–pro-B cells derived 
from WT, IL-7R  / , and IL-7 /  mice. The definition of pre–pro-B cells 
here is Lin B220 CD43 CD19 NK1.1 Ly-6C  cells. Removal of CD19  
cells from this analysis is critical to exclude the more mature B cell pro-
genitors from the pre–pro-B cell population (see Fig. S1). Open and filled 
histograms represent the expression level of various markers and the neg-
ative control stained with isotype-matched irrelevant antibodies, respectively. 
We did not stain pre–pro-B cells from IL-7R  /  mice with anti–IL-7R  anti-
bodies in this analysis. (D) The number of CLP, pre–pro-B, and pro-B cells 
in bone marrow from bilateral femurs and tibiae derived from WT (open 
circle), IL-7R  /  (closed circle), and IL-7 /  (closed square) mice. The 
absolute number of cells was calculated with total bone marrow cell num-
bers and the percentage of each cell population. The mean is indicated as 
a horizontal bar. Because IL-7R  is a marker to define CLPs, we did not 
determine the number of CLPs in IL-7R  /  mice. Asterisks denote signifi-
cant difference by Student’s t test; P   0.05. 
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maturational stage (B220
 
 
 
CD43
 
 
 
BP-1
 
 
 
HSA
 
high
 
 subset, frac-
tion C/C
 
 
 
 in Hardy’s nomenclature [13]; we simply denote
fraction C/C
 
 
 
 as fraction C hereafter in this paper) were al-
most absent, indicating that IL-7R signaling is required at an
earlier stage than the pro-B (fraction B or C) stage in B cell
development. The cell surface phenotype of pre–pro-B cells
derived from 
 
IL-7R
 
 
 
 
 
/
 
 
 
 and 
 
IL-7
 
 
 
/  mice was identical to
WT pre–pro-B cells (Fig. 1 C).
Expression of B cell–specific genes is impaired in pre–pro-B 
cells in the absence of IL-7R signaling
A recent study showed that lack of a cell survival factor, Mcl-1,
causes severe B cell developmental arrest at the pro-B cell
stage (20), although our previous studies suggest that antiapop-
totic signals via IL-7R may not be crucial in B cell develop-
ment (15, 16). We examined the expression of known
survival factor genes bcl-2, bcl-xL, and mcl-1 in WT and IL-
7R  /  pre–pro-B cells (Fig. 2 A). Expression levels of these
survival factors were comparable, indicating the dispensable
role of IL-7 for expression of these survival factors at the pre–
pro-B cell stage. Because the mcl-1 gene flanked with the loxP
sites is not deleted in pre–pro-B cells of CD19-CreMcl-1f/null
mice, it is not clear if Mcl-1 also plays an important role in
the pre–pro-B cell stage (20). Regardless, our gene expres-
sion profiling suggests that mcl-1 expression is not regulated
by IL-7R signaling pathway, at least in pre–pro-B cells.
We next examined the expression of various B cell–spe-
cific genes critical for B cell development in WT and IL-
7R  /  pre–pro-B cells. Notably, expression of EBF, Pax5,
and  5 was absent in IL-7R  /  pre–pro-B cells but was
present in WT pre–pro-B cells (Fig. 2 B). Ig  and Vpre-B ex-
pressions were also significantly reduced in IL-7R  /  pre–
pro-B cells. In contrast, E2A and PU.1, which regulate early
B cell development (1, 21), were normally expressed (Fig. 2
B). E2A function could be suppressed by direct association
with Id2 or Id3 (1), but we did not observe any elevated ex-
pression of Id2 or Id3 in IL-7R  /  pre–pro-B cells (Fig. 2
B). Because Ig , Ig ,  5, Vpre-B, RAG1, RAG2, and Pax5
genes are targets of E2A and EBF (1, 2, 5), we hypothesized
that the ablated expression of EBF might cause arrested B cell
development at the pre–pro-B stage in IL-7R  /  mice.
We further examined the expression of EBF at different
maturational stages of developing B cells. As shown in Fig. 2
C, we observed strong up-regulation of EBF expression at the
pro-B stage. EBF expression peaked at the small, nondividing
pre-B cell stage and declined at the immature-B cell stage
(Fig. 2 C). Because B cell development is arrested at the
B220 CD43 BP-1 HSA  (fraction A) stage in EBF /  mice
(22), EBF expression in pre–pro-B cells should be required
for the stage transition from the pre–pro-B to pro-B cell stage,
despite its lower expression level in the pre–pro-B population
compared with the more mature B cell progenitors.
EBF is a downstream target of IL-7R signaling at the 
pre–pro-B cell stage
Next, we examined the relationship between IL-7R signal-
ing and EBF expression in pre–pro-B cells. We purified pre–
pro-B cells from IL-7 /  mice and stimulated them with
IL-7 in vitro. EBF expression levels were analyzed by RT-
PCR. As shown in Fig. 3 A, there was no EBF expression in
pre–pro-B cells derived from IL-7 /  mice, as in the case
with IL-7R  /  pre–pro-B cells (Fig. 2 B). EBF expression
was up-regulated at 12 h after IL-7 stimulation, and its ex-
pression was maintained for at least 48 h (Fig. 3 A). We did
not observe any change of surface phenotype in these pre–
pro-B cells after 24 h of culture in the presence of IL-7 (Fig.
3 A), suggesting that initiation of EBF expression is a direct
consequence of IL-7 stimulation in pre–pro-B cells.
To determine the biological importance of EBF up-regu-
lation triggered by IL-7 stimulation, we examined whether
or not enforced EBF expression could rescue the impaired B
cell development in IL-7R  /  mice. IL-7R , EBF, and
Figure 2. Gene expression profiles in IL-7R  /  pre–pro-B cells. 
(A) Expression of antiapoptotic genes in WT and IL-7R  /  pre–pro-B cells 
were examined by RT-PCR. RNA was purified from 1.5   104 pre–pro-B cells 
(Lin B220 CD43 CD19 NK1.1 Ly-6C  cells), which were sorted twice in se-
quence (double sorted) from WT and IL-7R  /  BM cells. After double sorting, 
the purity of cells was  99% in reanalysis. (B) Expression of genes that are 
involved in B cell development in WT and IL-7R  /  pre–pro-B cells. RT-PCR 
analyses were done as in A. (C) Expression of EBF gene in various developing 
B cell populations. The cell populations used here are HSC (Lin /lowThy-
1.1lowc-KithighSca-I ), CLP (Lin c-KitlowSca-IlowThy-1.1 IL-7R  ), pre–pro-B 
(B220 CD43 CD19 NK1.1 Ly-6C ), pro-B (B220 CD43 CD19 HSAhigh), 
pre-B (B220 CD43 IgM ), and immature B (B220 IgM IgD ). The lineage 
cocktail (Lin) used for HSCs and CLPs also contained anti-B220 antibodies. 
Total RNA was purified from each doubly sorted population and subjected to 
quantification of EBF mRNAs by real-time PCR after first strand synthesis with 
reverse transcriptase. The amount of the first strand DNA applied was normal-
ized to the expression level of a reference gene, GAPDH. EBF expression in 
whole BM was arbitrarily defined as unit one. The mean value of more than 
three independent samples is shown. Range of error is too small to be dis-
played in the histogram.UP-REGULATION OF EBF EXPRESSION BY IL-7 RECEPTOR SIGNALS | Kikuchi et al. 1200
Pax5, as well as MSCV-IRES-GFP empty vector, were ret-
rovirally introduced into IL-7R  /  HSCs (CD45.2 ) for in
vivo reconstitution. 4   103 GFP  HSCs were injected into
sublethally irradiated RAG2 /  mice (CD45.1 ). We ana-
lyzed spleens in reconstituted mice at 5 wk after injection.
The top panels of Fig. 3 B show the frequency of CD19  B
cells in CD45.2  donor-derived cells. In this experimental
system, CD19  B cells were not detected in reconstituted
mice with IL-7R  /  HSCs introduced with empty vector,
but were clearly present in reconstituted mice with IL-7R  / 
HSCs infected with IL-7R  viruses (Fig. 3 B). Although
the frequency of B cells was lower than this positive control
(IL-7R  /  HSCs with ectopic IL-7R ), introduction of
EBF clearly rescued B cell development from IL-7R  / 
HSCs (Fig. 3 B). All of these CD19  cells were GFP  (not
depicted) and expressed B cell marker B220 and IgM on the
cell surface (Fig. 3 B, bottom). The absolute cell number of
the CD19 B220 IgM  spleen B cells from EBF  IL-7R  / 
HSCs (8.8   5.5   102) was  160 times lower than spleen B
cells from IL-7R  /  HSCs with ectopic IL-7R  (1.4   0.4  
105; Fig. 3 C). No mature B cells were observed from IL-
7R  /  HSCs introduced with Pax5 as well as introduction
of empty vectors (Fig. 3 B). These results demonstrated that
the enforced expression of EBF, but not Pax5, could rescue B
cell differentiation in the absence of IL-7R signaling. The
lower yield of mature B cells from IL-7R  /  HSC with ec-
topic EBF reemphasized the importance of IL-7 as a B cell
growth factor.
Figure 3. EBF expression is regulated by IL-7R signaling in B cell 
development. (A) Restoration of EBF expression in IL-7 /  pre–pro-B cells. 
1.2   104 pre–pro-B cells (B220 CD43 CD19 NK1.1 Ly-6C ) derived 
from IL-7 /  mice were cultured in the presence of 10 ng/ml IL-7 in 96-well 
plates. The same number of freshly isolated cells was used as a nonstimu-
lated control (time 0). Cells were harvested at the indicated time points and 
subjected to RT-PCR analysis of EBF expression. We also checked the cell 
surface phenotype of cells at 24 h after the culture. At this time point, no 
pro-B cells (CD19  or BP-1  cells) were developed from pre–pro-B cells 
(open histogram). Closed histogram represents background staining with 
isotype control antibodies. (B) IL-7R  /  HSCs (CD45.2 ) were infected 
with empty, IL-7R , EBF, Pax5, or STAT5 (1*6) retroviruses by spin infection 
and injected into sublethally irradiated RAG2 /  mice (CD45.1 ). 5 wk after 
injection, mice were killed and spleen cell suspensions were stained with 
antibodies for CD19, B220, and IgM, as well as for CD45.2. CD19 B220 IgM  
cells are mature B cells. Representative data from more than three samples 
are shown. We did not observe any immature B cells derived from EBF  
IL-7R  /  HSCs in bone marrow at this time point but did observe them at 
an earlier time point (Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20050158/DC1). (C) CD19 B220 IgM  cell numbers of reconsti-
tuted mice with IL-7R  /  HSCs infected with empty, IL-7R , EBF, Pax5, or 
STAT5 (1*6) retroviruses shown in B were calculated. The cell numbers are 
expressed as mean   SD.JEM VOL. 201, April 18, 2005 1201
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Activated STAT5 can induce EBF expression in 
pre–pro-B cells
STAT5 is a critical signal molecule downstream of IL-7R
(23). In reconstituted mice with IL-7R  /  HSCs that were
introduced with constitutive active STAT5 (STAT5 (1*6)),
we could see both differentiation and expansion of CD19 
B220 IgM  spleen B cells (3.5   1.4   105; Fig. 3, B and
C), consistent with a previous observation (24). We isolated
pre–pro-B cells from these reconstituted mice (Fig. 4 A) and
examined EBF expression. As shown in Fig. 4 B, EBF as
well as its downstream target genes, such as Pax5, Ig , and
 5, were expressed in IL-7R  /  pre–pro-B cells in the
presence of constitutive active STAT5. These data suggest
that STAT5 plays a central role in IL-7R signaling pathway
to activate EBF expression. In pro-B cells, STAT5 has been
shown to induce the expression of cyclin D2, pim-1, and bcl-xL,
which are involved in cell proliferation and survival (24).
Hence, the lack of induction of proliferation and/or survival
factors may be the reason why we could not observe B cell
expansion in mice reconstituted with IL-7R  /  HSCs in-
troduced with EBF (Fig. 3 C).
IL-7 has been considered to mainly function at the pro-B
cell stage in B cell development because pro-B cells prolifer-
ate extensively in response to IL-7 (25). In addition to the
function of IL-7 as a B cell growth factor, IL-7R signaling
regulates the accessibility of distal V segments of the IgH
genes, which leads to preferential rearrangement of distal V
to DJ in pro-B cells (11, 26). Also, IL-7 may be necessary for
pro-B cell survival through Mcl-1 expression (20). In this
study, we have demonstrated that IL-7 is necessary for EBF
expression in pre–pro-B cells, as well as for transition to
more mature stages during adult B cell development. Initia-
tion of EBF expression before the pre–pro-B cell stage might
be IL-7 independent, because EBF expression is observed
before the IL-7R   CLP stage (27). Our preliminary data
also suggests that CLPs derived from IL-7 /  mice expressed
a comparable level of EBF to WT (unpublished data).
Therefore, it is possible that IL-7 stimulation is necessary for
the maintenance of the EBF expression during the CLP to
pre–pro-B cell stage transition. In addition, it is intriguing to
know the regulation of EBF gene expression between fetal
and adult pre–pro-B cells because fetal B cell development is
IL-7 independent (28). Further studies are necessary to elu-
cidate how IL-7 can mediate these different biological pro-
cesses at different developmental stages of B lymphopoiesis.
MATERIALS AND METHODS
Mice. IL-7R  /  mice were obtained from The Jackson Laboratory. IL-
7 /  mice were provided by I.L. Weissman (Stanford University, Stanford,
CA), which were originally provided by R. Murray (DNAX Research In-
stitute, Palo Alto, CA). RAG2 /  mice were introduced with CD45.1 as
described previously (29). All mice were backcrossed onto C57BL/6 back-
ground for more than eight generations. Age-matched C57BL/6 mice were
used as WT control. The age of mice used in this study was between 4 and
8 wk old. Specifically, we used 8-wk-old mice in the experiment shown in
Fig. 1 D. All mice were bred in a specific pathogen-free environment at the
mouse facility of Duke University Medical Center. All experimental proce-
dures related to laboratory mice were done according to guidelines specified
by the institution.
Cell sorting and flow cytometric analysis. Antibodies used in this study
are listed in the online supplemental material. Preparation of single cell suspen-
sion and antibody staining of cells were done as previously described (15). Cell
sorting and cell surface phenotyping were performed on a FACSVantage SE
with a DiVa option (488 nm argon, 599 nm dye, and 408 nm krypton lasers;
BD Biosciences Flow Cytometry Systems), which is available in the FACS fa-
cility of Duke University Comprehensive Cancer Center. Data were analyzed
with the FlowJo software (Treestar). Dead cells were excluded from analyses
and sortings as positively stained cells by propidium iodide.
RT-PCR. Cells were sorted directly into 1.5-ml microcentrifuge tubes
with 1 ml TRIzol reagent (Invitrogen). Total RNA was purified based on
Figure 4. STAT5, a downstream signaling molecule of IL-7R, 
mediates EBF gene expression. (A) Donor-derived pre–pro-B cells 
(CD45.2 GFP B220 CD43 CD19 ) were purified from reconstituted mice 
with IL-7R  /  HSCs infected with STAT5 (1*6) retrovirus. (B) 1.0   104 
pre–pro-B cells derived from WT (left lane), IL-7R  /  mice (middle lane), 
and reconstituted mice with IL-7R  /  HSCs expressing STAT5 (1*6) (right 
lane) were used for analysis of B cell–specific gene expression by RT-PCR. 
EBF expression as well as expression of its targets, Pax5, Ig , and  5, were 
restored in pre–pro-B cells in the presence of constitutive active STAT5. 
Because IL-7R  expression was not detected in the right lane, there was 
no contamination of host-derived cells (RAG2 /  mice) in the sample.UP-REGULATION OF EBF EXPRESSION BY IL-7 RECEPTOR SIGNALS | Kikuchi et al. 1202
the manufactured instruction. First-strand cDNA was synthesized with Su-
perscript III reverse transcriptase and oligo-dT primers (Invitrogen). Verifi-
cation of the amount of first strand cDNA was done by amplification of
 -actin. Genes of interest were amplified by PCR with BD Advantage 2 PCR
Enzyme System (BD Biosciences) based on the manufactured protocol. In
experiments shown in Fig. 2 C, we quantified EBF expression using the
LightCycler system (Roche) after the first strand DNA synthesis. The prim-
ers for PCR are listed in the online supplemental material.
Retrovirus production and infection. Retroviral vectors used in this
study are shown in online supplemental material. STAT5A1*6, Mcl-1,
Pax5, and Bcl-2 cDNAs were provided by T. Kitamura (University of To-
kyo, Tokyo, Japan), S. Korsmeyer (Dana-Farber Cancer Institute, Boston,
MA), J. Parnes (Stanford University, Stanford, CA), and K. Sugamura (To-
hoku University, Sendai, Japan), respectively. Retroviruses were prepared
as described previously (30). For retroviral infection, 2   104 IL-7R  / 
HSCs were placed in 200  l X-VIVO medium (BIO-WHITTKER) sup-
plemented with 1% BSA, 10 ng/ml IL-11 and TPO, 50 ng/ml SCF (R&D
Systems), and 50% of viral supernatants in a well of round bottom 96-well
plates. The culture plate was centrifuged at 2,000 rpm at 22 C for 2 h (spin
infection). After the spin infection, cells were incubated at 37 C. After 24-h
culture, the frequency of GFP  cells was verified by FACS. The cell num-
bers for injection were adjusted by the GFP  cell frequency so that 4   103
GFP  cells were injected into a mouse.
In vivo reconstitution assay. IL-7R  /  HSCs (CD45.2 ) infected with
retroviruses were injected into retroorbital venous sinus of sublethally irra-
diated (400 rad) RAG2 /  mice (CD45.1 ). 5 wk after injection, mice
were killed and differentiation of donor-derived cells was assessed by FACS.
In vitro stimulation of pre–pro-B cells with IL-7. pre–pro-B cells de-
rived from IL-7 /  mice were placed in a well of 96-well plates in IMDM
with 10% FCS, 50  M 2-ME, and 10 ng/ml IL-7 (R&D Systems). Cells
were harvested at the time points indicated in the figures and subjected to
RT-PCR analyses.
Online supplemental material. A more detailed characterization of pre–
pro-B cells is shown in Fig. S1. Rescue of B precursor compartments by ec-
topic EBF in IL-7R  /  HSCs is shown in Fig. S2. Antibodies, retroviral
vectors, and PCR primers used in this study are listed in the online supple-
mental material. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20050158/DC1.
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